MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

MDT

98.74

-1.06%↓

A

145.66

-1.47%↓

VEEV

241.02

+0.99%↑

HQY

98.46

+0.84%↑

PHR.US

16.88

-3.21%↓

Search

Simulations Plus Inc

Cerrado

SectorSanidad

17.94 -5.13

Resumen

Variación precio

24h

Actual

Mínimo

17.8

Máximo

18.77

Métricas clave

By Trading Economics

Ingresos

-681K

Ventas

17M

P/B

Media del Sector

48.528

87.826

BPA

-0.034

Rentabilidad por dividendo

0.48

Margen de beneficios

-3.9

Empleados

212

EBITDA

-79M

-74M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+15.85% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.48%

2.26%

Próximas Ganancias

2 abr 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

19M

387M

Apertura anterior

23.07

Cierre anterior

17.94

Noticias sobre sentimiento de mercado

By Acuity

9%

91%

11 / 372 Clasificación en Healthcare

Simulations Plus Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

8 ene 2026, 23:08 UTC

Adquisiciones, fusiones, absorciones

Rio Tinto, Glencore in Talks to Form World's Biggest Miner -- 3rd Update

8 ene 2026, 21:39 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Restart Merger Talks -- 2nd Update

8 ene 2026, 20:54 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Restart Merger Talks -- Update

8 ene 2026, 20:44 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Restart Merger Talks

8 ene 2026, 17:05 UTC

Adquisiciones, fusiones, absorciones

Chinese Anta Sports Products Offers to Buy Pinault Family's Stake in Puma, Reuters Says, Citing Unnamed Sources

8 ene 2026, 16:43 UTC

Principales Movimientos del Mercado

Babcock & Wilcox Shares Rise on Siemens Deal for Data Center Project

8 ene 2026, 23:44 UTC

Charlas de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

8 ene 2026, 23:37 UTC

Charlas de Mercado

Gold Steady, Underpinned by Geopolitical Risks -- Market Talk

8 ene 2026, 22:42 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

8 ene 2026, 22:42 UTC

Charlas de Mercado

RBA Still Battling a Troubling Inflation Outlook, Says TD -- Market Talk

8 ene 2026, 22:30 UTC

Adquisiciones, fusiones, absorciones

Glencore, Rio Tinto Confirm Early Merger Talks -- Barrons.com

8 ene 2026, 21:53 UTC

Ganancias

These Stocks Moved the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 ene 2026, 21:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 ene 2026, 21:50 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 ene 2026, 21:10 UTC

Adquisiciones, fusiones, absorciones

Rio Tinto Says Current Expectation That Any Deal Would Involve Buying Glencore Via Scheme of Arrangement

8 ene 2026, 21:09 UTC

Charlas de Mercado

Oil Rises As Trump Said to Back Russia Sanctions Bill -- Market Talk

8 ene 2026, 21:09 UTC

Adquisiciones, fusiones, absorciones

Rio Tinto Confirms in Talks With Glencore Over Possible Merger

8 ene 2026, 20:21 UTC

Charlas de Mercado

U.S. Natural Gas Futures Down Despite Inventory Draw -- Market Talk

8 ene 2026, 19:44 UTC

Charlas de Mercado

Gold's Shine Masks Deep Drops in Canada Steel, Aluminum Exports -- Market Talk

8 ene 2026, 18:50 UTC

Charlas de Mercado

Mexico's Industrial Production Seen Lower in November -- Market Talk

8 ene 2026, 17:48 UTC

Ganancias

These Stocks Are Moving the Most Today: Lockheed, Northrop, Alphabet, Applied Digital, Bloom Energy, Neogen, and More -- Barrons.com

8 ene 2026, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

8 ene 2026, 17:20 UTC

Charlas de Mercado

Auto & Transport Roundup: Market Talk

8 ene 2026, 17:20 UTC

Charlas de Mercado

Health Care Roundup: Market Talk

8 ene 2026, 17:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

8 ene 2026, 16:45 UTC

Charlas de Mercado

Goldman Lifts 1H LME Copper Forecast -- Market Talk

8 ene 2026, 16:03 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

8 ene 2026, 16:03 UTC

Charlas de Mercado

Currency Markets Could Be Underpricing Medium-Term Risks -- Market Talk

8 ene 2026, 16:02 UTC

Charlas de Mercado

U.S. Natural Gas Inventories Fall As Expected -- Market Talk

8 ene 2026, 15:23 UTC

Adquisiciones, fusiones, absorciones

Paramount Defends Its Hostile Bid for Warner -- Update

Comparación entre iguales

Cambio de precio

Simulations Plus Inc previsión

Precio Objetivo

By TipRanks

15.85% repunte

Estimación a 12 Meses

Media 22 USD  15.85%

Máximo 25 USD

Mínimo 19 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Simulations Plus Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

5 ratings

2

Comprar

3

Mantener

0

Vender

Sentimiento

By Acuity

11 / 372 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat